Tonix Pharm Holdings (TNXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,001 | -9,450 | -6,821 | -5,089 | -2,015 |
| Depreciation Amortization | 4 | 210 | 206 | 202 | 199 |
| Accounts payable and accrued liabilities | 44 | 132 | 2 | -208 | -513 |
| Other Working Capital | 232 | 268 | 151 | 66 | -422 |
| Other Operating Activity | 359 | 3,127 | 2,254 | 2,121 | 973 |
| Operating Cash Flow | $-1,362 | $-5,713 | $-4,208 | $-2,907 | $-1,778 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -36 | -36 | -34 | N/A |
| Investing Cash Flow | $N/A | $-36 | $-36 | $-34 | $0 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 320 | N/A | N/A | N/A |
| Debt Issued | N/A | 390 | N/A | N/A | N/A |
| Debt Repayment | N/A | -150 | -150 | -150 | -150 |
| Common Stock Issued | N/A | 6,933 | 4,388 | 4,388 | 4,388 |
| Financing Cash Flow | $N/A | $7,493 | $4,238 | $4,238 | $4,238 |
| Beginning Cash Position | 1,786 | 41 | 41 | 41 | 41 |
| End Cash Position | 424 | 1,785 | 36 | 1,338 | 2,501 |
| Net Cash Flow | $-1,362 | $1,744 | $-6 | $1,297 | $2,460 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,362 | -5,713 | -4,208 | -2,907 | -1,778 |
| Capital Expenditure | N/A | -36 | -36 | -34 | N/A |
| Free Cash Flow | -1,362 | -5,749 | -4,243 | -2,941 | -1,778 |